Literature DB >> 8484678

Levels of insulin related growth factor 1 in osteoarthritis of the knee.

T E McAlindon1, J D Teale, P A Dieppe.   

Abstract

OBJECTIVES: Insulin related growth factor 1 (IGF1) is an important growth promoting peptide which has anabolic effects on in vitro cartilage metabolism. The fact that serum levels tend to decrease in elderly subjects while osteoarthritis (OA) increases in prevalence suggests that suboptimal levels may play a part in the development of OA. This study therefore considers the hypothesis that IGF1 levels are low in subjects with OA of the knee.
METHODS: Serum IGF1 levels in a community derived sample with symptomatic knee OA were compared with those in normal controls matched by age and gender. Overall radiographic score, osteophyte score, sclerosis score, and joint space narrowing score were correlated with IFG1 levels.
RESULTS: One hundred and seventy-seven elderly subjects (83 with knee pain, 94 without knee pain) participated, allowing the identification of 78 case-control pairs matched by age and gender (mean 71.8 v 71.9 years, SD 7.6 for the two groups). No difference was found in serum IGF1 levels between the cases and controls (mean(SD) 15.9(4.7) nmol/l, for cases, 16.4(5.4) for controls). Significant negative correlations were found between IGF1 levels and age, total radiographic score, osteophyte score, and sclerosis score. In a multiple regression model, however, only age remained significant.
CONCLUSIONS: This study provides no evidence that serum IGF1 levels are low in OA. Apparent correlations with radiographic features of OA may be due to the confounding effects of age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484678      PMCID: PMC1005023          DOI: 10.1136/ard.52.3.229

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  The prevalence and severity of major disabling conditions--a reappraisal of the government social survey on the handicapped and impaired in Great Britain.

Authors:  E M Badley; R P Thompson; P H Wood
Journal:  Int J Epidemiol       Date:  1978-06       Impact factor: 7.196

2.  Effects of hormones and drugs on cartilage repair.

Authors:  P Franchimont; C Bassleer; Y Henrotin
Journal:  J Rheumatol Suppl       Date:  1989-08

Review 3.  Factors involved in the regulation of proteoglycan metabolism in articular cartilage.

Authors:  T I Morales; V C Hascall
Journal:  Arthritis Rheum       Date:  1989-10

4.  Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations.

Authors:  J L van Saase; L K van Romunde; A Cats; J P Vandenbroucke; H A Valkenburg
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

5.  Relationship between arthroscopic evidence of cartilage damage and radiographic evidence of joint space narrowing in early osteoarthritis of the knee.

Authors:  R S Fife; K D Brandt; E M Braunstein; B P Katz; K D Shelbourne; L A Kalasinski; S Ryan
Journal:  Arthritis Rheum       Date:  1991-04

6.  Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia.

Authors:  J D Teale; V Marks
Journal:  Clin Endocrinol (Oxf)       Date:  1990-07       Impact factor: 3.478

7.  Knee pain and disability in the community.

Authors:  T E McAlindon; C Cooper; J R Kirwan; P A Dieppe
Journal:  Br J Rheumatol       Date:  1992-03
  7 in total
  8 in total

Review 1.  Prognosis of osteoarthritis.

Authors:  M C Hochberg
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

Review 2.  Clinical implications of osteoarthritis and ageing.

Authors:  D Hamerman
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

3.  Insulin-like growth factor I gene promoter polymorphism, collagen type II alpha1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study.

Authors:  G Zhai; F Rivadeneira; J J Houwing-Duistermaat; I Meulenbelt; C Bijkerk; A Hofman; J B J van Meurs; A G Uitterlinden; H A P Pols; P E Slagboom; C M van Duijn
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 4.  The relationship between osteoarthritis and osteoporosis.

Authors:  Gun-Il Im; Min-Kyu Kim
Journal:  J Bone Miner Metab       Date:  2013-11-07       Impact factor: 2.626

Review 5.  Effects of GH/IGF axis on bone and cartilage.

Authors:  Manisha Dixit; Sher Bahadur Poudel; Shoshana Yakar
Journal:  Mol Cell Endocrinol       Date:  2020-10-14       Impact factor: 4.102

6.  Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.

Authors:  M E Lloyd; D J Hart; D Nandra; T E McAlindon; M Wheeler; D V Doyle; T D Spector
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

7.  RIPK1 suppresses apoptosis mediated by TNF and caspase-3 in intervertebral discs.

Authors:  Xubin Qiu; Ming Zhuang; Ziwen Lu; Zhiwei Liu; Dong Cheng; Chenlei Zhu; Jinbo Liu
Journal:  J Transl Med       Date:  2019-04-27       Impact factor: 5.531

Review 8.  Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments (Review).

Authors:  Shuyu Liu; Zhenhan Deng; Kang Chen; Shengsheng Jian; Feifei Zhou; Yuan Yang; Zicai Fu; Huanyu Xie; Jianyi Xiong; Weimin Zhu
Journal:  Mol Med Rep       Date:  2022-01-28       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.